thymoquinone has been researched along with Bone Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Asemi, Z; Homayoonfal, M; Yousefi, B | 1 |
| Ahmadi, M; Ahmadzadeh, H; Alemi, F; Bazavar, M; Golchin, A; Malakoti, F; Maleki, M; Yousefi, B | 1 |
| Majidinia, M; Malakoti, F; Sanapour, N; Shanebandi, D; Soleimanpour, J; Targhazeh, N; Yousefi, B | 1 |
| Khyavi, PA; Shanehbandi, D; Soleimanpour, J; Valizadeh, A; Yousefi, B | 1 |
| Bayram, R; Benek, SB; Sarman, H | 1 |
| Chen, QY; Cheng, SW; Liao, W; Lin, ZQ; Liu, A; Liu, HX; Peng, L; Shen, WD; Shen, Y; Xu, HZ; Yang, SZ; Ying, XZ | 1 |
| Bajbouj, K; Diestel, A; Gali-Muhtasib, H; Roepke, M; Roessner, A; Schneider-Stock, R; Schonfeld, P; Walluscheck, D | 1 |
1 review(s) available for thymoquinone and Bone Cancer
| Article | Year |
|---|---|
Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis.
Topics: Apoptosis; Benzoquinones; Bone Neoplasms; Cell Line, Tumor; Child; Humans; Nigella sativa; Osteosarcoma | 2022 |
6 other study(ies) available for thymoquinone and Bone Cancer
| Article | Year |
|---|---|
The Effect of TQ and Cis in OS.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Humans; Osteosarcoma | 2022 |
Thymoquinone Augments Methotrexate-Induced Apoptosis on Osteosarcoma Cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Bone Neoplasms; Caspase 9; Cell Line, Tumor; Cell Proliferation; Humans; Methotrexate; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2 | 2022 |
Thymoquinone Potentiates Methotrexate Mediated-Apoptosis in Saos-2 Osteosarcoma Cell Line.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Humans; Methotrexate; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2 | 2022 |
Anticancer drugs with chemotherapeutic interactions with thymoquinone in osteosarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Bone Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Humans; Organoplatinum Compounds; Osteosarcoma; Oxaliplatin; Tumor Cells, Cultured | 2016 |
Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
Topics: Animals; Antigens, CD34; Antineoplastic Agents; Apoptosis; Benzoquinones; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Human Umbilical Vein Endothelial Cells; Humans; Inhibitor of Apoptosis Proteins; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; NF-kappa B; Oligopeptides; Osteosarcoma; Signal Transduction; Survivin; X-Linked Inhibitor of Apoptosis Protein | 2013 |
Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Bone Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Damage; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Immunohistochemistry; Middle Aged; Osteosarcoma; Oxidative Stress; Rats; Treatment Outcome | 2007 |